Showing 21 - 30 of 943,425
The mentor and the protégé -- The big bet -- The playbook -- The rookies -- The ecosystem -- The salesman -- The program -- The stand-off -- The performer -- The spiel -- The whistleblower -- The whales -- An interloper -- 'Let's get a few more' -- Fall guy -- 'It's going down' -- The pyramid...
Persistent link: https://www.econbiz.de/10012543038
In theory, equilibrium profits for drug patent holders would not involve significant restraints on production and … through insurance plans. This paper provides a quantitative model consistent with the theory and evidence in which pharmacy …
Persistent link: https://www.econbiz.de/10013334448
Proposed "delinking" legislation would prohibit Pharmacy Benefit Managers (PBMs) from being remunerated based on the rebates and discounts they negotiate for drug insurance plans serving Medicare beneficiaries. This policy would significantly change drug pricing and utilization and shift...
Persistent link: https://www.econbiz.de/10014372424
Persistent link: https://www.econbiz.de/10013182698
Persistent link: https://www.econbiz.de/10012310127
Persistent link: https://www.econbiz.de/10011405941
This paper provides the first quantitative economic models of pharmacy benefit management regulation. The price-theoretic models allow for various market frictions and imperfections including market power, coordination costs, tax distortions, and incomplete innovation incentives. A rigorous...
Persistent link: https://www.econbiz.de/10014247918
This paper provides the first quantitative economic models of pharmacy benefit management regulation. The price-theoretic models allow for various market frictions and imperfections including market power, coordination costs, tax distortions, and incomplete innovation incentives. A rigorous...
Persistent link: https://www.econbiz.de/10014255482
Persistent link: https://www.econbiz.de/10012586512
Persistent link: https://www.econbiz.de/10001608852